Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Sumitomo Dainippon Pharma Co ( (JP:4506) ) is now available.
Sumitomo Pharma Co., Ltd. has announced the refinancing of its existing borrowings through a syndicated loan to stabilize its financial position after a breach of financial covenants. The refinancing involves a term loan and a commitment line totaling 233 billion yen, with minimal expected impact on the company’s financial results for the fiscal year ending March 2025.
More about Sumitomo Dainippon Pharma Co
Sumitomo Pharma Co., Ltd. is a pharmaceutical company based in Osaka, Japan. The company is involved in the development and marketing of pharmaceutical products and has a strategic focus on expanding its market presence through acquisitions and alliances.
YTD Price Performance: 26.40%
Average Trading Volume: 678
Technical Sentiment Signal: Hold
Current Market Cap: $1.91B
See more data about 4506 stock on TipRanks’ Stock Analysis page.